article thumbnail

The potential of AI in pharma R&D

Pharmaceutical Technology

Developing a new drug is a monumental achievement — the reward of years of research and innovation. Successful innovation requires enormous effort from countless project teams that build on the medical, scientific and technological research and development of generations before them.

article thumbnail

Why VCs fell in love with pharma R&D in 2021

pharmaphorum

That culture clash makes it hard to innovate the world of pharma at scale and with any rapidity. And investment in pharma followed suit: pharma companies were looked at as stable assets — reliable but unlikely to balloon in value like a tech company might. Start-ups move fast and break things.

article thumbnail

Rethinking the pharma R&D lifecycle with AI in mind

Drug Discovery World

The rest of the pharma R&D system — how drugs are developed, tested, approved, and manufactured — will need to accommodate this vast increase in speed and scale. Pharma R&D has been heading in the wrong direction, becoming progressively less efficient over the last few decades.